27255600|t|Cognition Enhancing Activity of Sulforaphane Against Scopolamine Induced Cognitive Impairment in Zebra Fish (Danio rerio)
27255600|a|Several epidemiological studies have shown that consumption of large quantities of vegetables especially cruciferous vegetables (Broccoli and Brussels sprouts) can protect against chronic diseases. Sulforaphane, an isothiocynate found in cruciferous vegetables has been demonstrated to have neuroprotective effects in several experimental paradigms. This study was undertaken to examine the effect of sulforaphane on cognitive impairment in zebra fish model using a novel method of fear conditioning. Initially, the normal behaviour of zebra fishes was studied in light-dark tank for 10 min daily for 10 days. Fishes were then divided into seven groups of twelve in each. Group I served as normal, group II served as fear conditioned control, group III and group IV were sulforaphane (25 µM/L) and piracetam (200 mg/L) treated respectively. Group V served as scopolamine (400 µM/L) induced memory impairment fishes. Group VI and VII were sulforaphane (25 µM/L) and piracetam (200 mg/L) treated scopolamine induced memory impairment groups respectively. In normal behavioural analysis, fishes preferred to stay in dark compartment. The average number of entries into the dark and time spent in dark were significantly more. Fishes in group II to VII were individually subjected to fear conditioning passive avoidance task and evaluated for learned task memory. It was observed that the average number of entries into dark and time spent in dark were significantly decreased. After exposure to respective treatment fishes in group III to VII were subjected to cognitive evaluation. There was no significant difference in cognition of group III and IV fishes exposed to sulforaphane and piracetam alone respectively. Fishes exposed to scopolamine showed a significant cognitive impairment. Sulforaphane exposure prior to scopolamine significantly retained the memory of learned task. These findings suggest that sulforaphane might be a promising therapeutic agent for cognitive enhancement in Alzheimer's disease.
27255600	0	9	Cognition	T041	C0009240
27255600	10	19	Enhancing	T052	C2349975
27255600	20	28	Activity	T078	C1561536
27255600	32	44	Sulforaphane	T109,T121	C0163159
27255600	45	52	Against	T080	C0521124
27255600	53	64	Scopolamine	T109,T121	C0036442
27255600	65	72	Induced	T169	C0205263
27255600	73	93	Cognitive Impairment	T048	C0338656
27255600	97	107	Zebra Fish	T013	C0043457
27255600	109	120	Danio rerio	T013	C0043457
27255600	122	129	Several	T081	C0443302
27255600	130	153	epidemiological studies	T062	C0002783
27255600	170	181	consumption	T052	C2983605
27255600	185	190	large	T081	C0549177
27255600	191	201	quantities	T081	C1265611
27255600	205	215	vegetables	T168	C0042440
27255600	227	249	cruciferous vegetables	T168	C0453113
27255600	251	259	Broccoli	T168	C0330499
27255600	264	280	Brussels sprouts	T168	C0330501
27255600	294	301	against	T080	C0521124
27255600	302	318	chronic diseases	T047	C0008679
27255600	320	332	Sulforaphane	T109,T121	C0163159
27255600	337	350	isothiocynate	T109	C0029224
27255600	351	356	found	T033	C0150312
27255600	360	382	cruciferous vegetables	T168	C0453113
27255600	413	436	neuroprotective effects	T169	C0815279
27255600	440	447	several	T081	C0443302
27255600	448	470	experimental paradigms	T062	C0681797
27255600	477	482	study	T062	C2603343
27255600	513	519	effect	T080	C1280500
27255600	523	535	sulforaphane	T109,T121	C0163159
27255600	539	559	cognitive impairment	T048	C0338656
27255600	563	573	zebra fish	T013	C0043457
27255600	574	579	model	T050	C0012644
27255600	588	593	novel	T080	C0205314
27255600	594	600	method	T170	C0025663
27255600	604	621	fear conditioning	T041	C0009649
27255600	638	644	normal	T080	C0205307
27255600	645	654	behaviour	T053	C0004927
27255600	658	670	zebra fishes	T013	C0043457
27255600	675	682	studied	T062	C2603343
27255600	686	701	light-dark tank	T073	C0337123
27255600	713	718	daily	T079	C0332173
27255600	726	730	days	T079	C0439228
27255600	732	738	Fishes	T013	C0043457
27255600	749	756	divided	T169	C0332849
27255600	762	767	seven	T081	C0205453
27255600	768	774	groups	UnknownType	C0681860
27255600	778	784	twelve	T081	C0205458
27255600	788	792	each	T081	C1457900
27255600	794	801	Group I	UnknownType	C0681860
27255600	812	818	normal	T080	C0205307
27255600	820	828	group II	UnknownType	C0681860
27255600	839	863	fear conditioned control	T041	C0009649
27255600	865	874	group III	UnknownType	C0681860
27255600	879	887	group IV	UnknownType	C0681860
27255600	893	905	sulforaphane	T109,T121	C0163159
27255600	920	929	piracetam	T109,T121	C0031977
27255600	941	948	treated	T169	C1522326
27255600	963	970	Group V	UnknownType	C0681860
27255600	981	992	scopolamine	T109,T121	C0036442
27255600	1004	1011	induced	T169	C0205263
27255600	1012	1029	memory impairment	T048	C0233794
27255600	1030	1036	fishes	T013	C0043457
27255600	1038	1046	Group VI	UnknownType	C0681860
27255600	1051	1054	VII	UnknownType	C0681860
27255600	1060	1072	sulforaphane	T109,T121	C0163159
27255600	1087	1096	piracetam	T109,T121	C0031977
27255600	1108	1115	treated	T169	C1522326
27255600	1116	1127	scopolamine	T109,T121	C0036442
27255600	1128	1135	induced	T169	C0205263
27255600	1136	1153	memory impairment	T048	C0233794
27255600	1154	1160	groups	UnknownType	C0681860
27255600	1178	1184	normal	T080	C0205307
27255600	1185	1205	behavioural analysis	T058	C1160858
27255600	1207	1213	fishes	T013	C0043457
27255600	1235	1239	dark	T080	C0332582
27255600	1240	1251	compartment	T082	C0449719
27255600	1257	1264	average	T081	C1510992
27255600	1265	1271	number	T081	C0237753
27255600	1275	1282	entries	T071	C1551338
27255600	1292	1296	dark	T080	C0332582
27255600	1301	1305	time	T079	C0040223
27255600	1315	1319	dark	T080	C0332582
27255600	1325	1343	significantly more	T081	C4055637
27255600	1345	1351	Fishes	T013	C0043457
27255600	1355	1363	group II	UnknownType	C0681860
27255600	1367	1370	VII	UnknownType	C0681860
27255600	1402	1419	fear conditioning	T041	C0009649
27255600	1420	1442	passive avoidance task	T060	C0683443
27255600	1447	1456	evaluated	T058	C0220825
27255600	1461	1480	learned task memory	T041	C0025260
27255600	1489	1497	observed	T169	C1441672
27255600	1507	1514	average	T081	C1510992
27255600	1515	1521	number	T081	C0237753
27255600	1525	1532	entries	T071	C1551338
27255600	1538	1542	dark	T080	C0332582
27255600	1547	1551	time	T079	C0040223
27255600	1561	1565	dark	T080	C0332582
27255600	1571	1584	significantly	T081	C0237881
27255600	1585	1594	decreased	T081	C0205216
27255600	1602	1613	exposure to	T080	C0332157
27255600	1625	1634	treatment	T169	C1522326
27255600	1635	1641	fishes	T013	C0043457
27255600	1645	1654	group III	UnknownType	C0681860
27255600	1658	1661	VII	UnknownType	C0681860
27255600	1680	1689	cognitive	T041	C0009240
27255600	1690	1700	evaluation	T058	C0220825
27255600	1712	1726	no significant	T033	C1273937
27255600	1727	1737	difference	T080	C1705242
27255600	1741	1750	cognition	T041	C0009240
27255600	1754	1763	group III	UnknownType	C0681860
27255600	1768	1770	IV	UnknownType	C0681860
27255600	1771	1777	fishes	T013	C0043457
27255600	1778	1788	exposed to	T080	C0332157
27255600	1789	1801	sulforaphane	T109,T121	C0163159
27255600	1806	1815	piracetam	T109,T121	C0031977
27255600	1836	1842	Fishes	T013	C0043457
27255600	1843	1853	exposed to	T080	C0332157
27255600	1854	1865	scopolamine	T109,T121	C0036442
27255600	1875	1886	significant	T081	C0237881
27255600	1887	1907	cognitive impairment	T048	C0338656
27255600	1909	1921	Sulforaphane	T109,T121	C0163159
27255600	1940	1951	scopolamine	T109,T121	C0036442
27255600	1952	1965	significantly	T081	C0237881
27255600	1979	1985	memory	T041	C0025260
27255600	1989	1996	learned	T041	C0023185
27255600	1997	2001	task	T169	C1317878
27255600	2009	2017	findings	T033	C0243095
27255600	2018	2025	suggest	T078	C1705535
27255600	2031	2043	sulforaphane	T109,T121	C0163159
27255600	2065	2082	therapeutic agent	T121	C1611640
27255600	2087	2096	cognitive	T041	C0009240
27255600	2097	2108	enhancement	T052	C2349975
27255600	2112	2131	Alzheimer's disease	T047	C0002395